Silverback Therapeutics, Inc.·4

May 4, 5:12 PM ET

Odegard Valerie 4

4 · Silverback Therapeutics, Inc. · Filed May 4, 2022

Insider Transaction Report

Form 4
Period: 2022-05-02
Odegard Valerie
President and CSO
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-02+90,46790,467 total
    Exercise: $3.15Exp: 2032-05-01Common Stock (90,467 underlying)
  • Award

    Common Stock

    2022-05-02+45,23361,639 total
Footnotes (2)
  • [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The shares subject to the option will vest on May 2, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION